Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
     J05A DIRECT ACTING ANTIVIRALS
       J05AA Thiosemicarbazones
       J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
       J05AC Cyclic amines
       J05AD Phosphonic acid derivatives
       J05AE Protease inhibitors [DG:DG01647]
         J05AE01 Saquinavir [DG:DG00653]
           D00429  Saquinavir (JAN/USP/INN)
           D01160  Saquinavir mesylate (USP)
         J05AE02 Indinavir [DG:DG00654]
           C07051  Indinavir
           D03833  Indinavir (USAN)
           D00897  Indinavir sulfate (USP)
           D02861  Indinavir sulfate ethanolate (JAN)
         J05AE03 Ritonavir
           D00427  Ritonavir (JAN/USP/INN) <JP/US>
         J05AE04 Nelfinavir [DG:DG00655]
           D08259  Nelfinavir (INN)
           D00899  Nelfinavir mesylate (USAN/INN) <US>
         J05AE05 Amprenavir
           D00894  Amprenavir (JAN/USAN/INN)
         J05AE07 Fosamprenavir [DG:DG00656]
           D02497  Fosamprenavir (INN)
           D02867  Fosamprenavir calcium hydrate (JAN)
           D03835  Fosamprenavir calcium (USAN) <US>
           D03837  Fosamprenavir sodium (USAN)
         J05AE08 Atazanavir [DG:DG00657]
           D07471  Atazanavir (INN)
           D01276  Atazanavir sulfate (JAN/USAN) <US>
         J05AE09 Tipranavir [DG:DG00658]
           D08605  Tipranavir (INN) <US>
           D03843  Tipranavir disodium (USAN)
         J05AE10 Darunavir [DG:DG00659]
           D03656  Darunavir (USAN/INN) <US>
           D06478  Darunavir ethanolate (JAN) <JP/US>
           D12637  Darunavir hydrate <US>
           D12752  Darunavir propylene glycolate <US>
         J05AE16 Ensitrelvir [DG:DG03269]
           D12619  Ensitrelvir (USAN/INN)
           D12353  Ensitrelvir fumarate (USAN) <JP>
         J05AE30 Nirmatrelvir and ritonavir
           D12269  Nirmatrelvir and ritonavir <JP/US>
       J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
       J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
       J05AH Neuraminidase inhibitors [DG:DG02842]
       J05AJ Integrase inhibitors [DG:DG03135]
       J05AP Antivirals for treatment of HCV infections
       J05AR Antivirals for treatment of HIV infections, combinations
       J05AX Other antivirals
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 26, 2026
According to WHO's ATC 2026

» Japanese version